Skip to main content

Table 1 Demographic and clinical characteristics of healthy controls and PD patients

From: Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study

Cohort Gender
(M/F)
Age
(years)
Duration of disease (years) UPDRS PDRP Z-score
Preoperative baseline Post-operation Preoperative baseline Post-operation
3 months 12 months 3 months 12 months
Cohort I
HC1 15/18 57.4 ± 10.5 0 ± 1.0
PD1 15/18 58.1 ± 10.3 4.3 ± 4.1 25.2 ± 14.4 2.74 ± 1.18
Cohort II
HC2 4/5 61.7 ± 7.3 0 ± 0.52
PD2 (patients underwent DBS)
1 F 50 8 49 21 60 3.01 0.11 1.83
2 M 66 19 62 53 69 1.61 − 0.18 0.17
3 M 62 10 51 10 37 2.42 1.97 2.28
4 F 72 5 50 12 31 1.52 − 0.40 0.39
5 M 53 17 39 30 4.21 2.84
6 F 54 13 52 31 2.89 2.77
7 F 77 7 51 24 3.71 2.53
8 F 69 4 58 56 2.69 2.11
9 M 65 6 35 10 0.72 0.26
Total 4/5 63.1 ± 9.2 9.9 ± 5.3 49.7 ± 8.4 27.4 ± 17.3 49.3 ± 18.2 2.53 ± 1.11 1.33 ± 1.35 1.17 ± 1.04
  1. Data are given as mean ± standard deviation
  2. UPDRS Unified Parkinson’s Disease Rating Scale